DGX vs RCUS · P/E 22, rev $5.94B vs rev $58.0M
Quest Diagnostics Incorporated (DGX) versus Arcus Biosciences Inc (RCUS) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported RCUS revenue for 2026-06-30 was $58.0M. Net income was -$219.0M. RCUS currently screens at market cap $885.2M.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. RCUS currently screens at market cap $885.2M.
Not investment advice. Open the DGX and RCUS stock pages for the full models.
Not investment advice.